FDA wants more data on Wyeth osteoporosis drug (AP via Yahoo! Finance)
Wyeth said Friday that U.S. regulators have again denied approval of the drug maker’s osteoporosis drug bazedoxifene requesting additional information on stroke and blood clot issues.